MJNE (OTCMKTS:MJNE) is a development‐stage company focused on research, development and commercialization of cannabinoid‐based wellness products. Since its founding, MJNE has positioned itself as an innovator in the fast‐evolving hemp and cannabis space, leveraging proprietary extraction and formulation technologies to address a broad spectrum of consumer needs. The company’s mission is to bridge scientific research with high‐quality manufacturing practices, delivering standardized, lab-verified products that appeal to both medical and lifestyle markets.
The company’s core activities include the extraction and purification of cannabinoids from hemp biomass, formulation of ingestible oils, topicals and edibles, and scale‐up through GMP-certified manufacturing partners. MJNE’s proprietary extraction platform is designed to maximize yield and preserve the integrity of key phyto-compounds, enabling the development of full-spectrum, broad-spectrum and isolate product lines. Beyond finished goods, MJNE offers white-label solutions and contract‐manufacturing services to third-party brands seeking to enter the cannabinoid space without in-house production capabilities.
MJNE serves a diverse geographic footprint, with operations and distribution channels spanning the United States, Canada and select European markets. In the U.S., the company has secured state‐level licenses and established partnerships with regional dispensaries, while in Canada it works under Health Canada’s Industrial Hemp Regulations. MJNE is also exploring market entry in emerging European jurisdictions, collaborating with local growers and regulatory consultants to navigate evolving compliance frameworks. Its distribution strategy combines direct-to-consumer e-commerce with wholesale supply agreements to mid- and large-scale retail networks.
The leadership team at MJNE brings together seasoned executives from the pharmaceutical, biotech and consumer‐packaged goods industries. Under the guidance of its chief executive, MJNE has forged strategic alliances with academic institutions and contract research organizations to advance product development and clinical research initiatives. The board of directors includes individuals with extensive experience in regulatory affairs, supply-chain management and international business development, positioning MJNE for sustainable growth as regulatory landscapes and consumer demand continue to mature.
AI Generated. May Contain Errors.
